Louis J Aronne

17PUBLICATIONS
55CO-AUTHORS
Food properties (incl. characteristics and health benefits)AutoimmunityCancer geneticsPharmacogenomicsOptical technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 12, 2026
Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial.

|Mar 02, 2026
Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial.

Steven B Heymsfield, Louis J Aronne, Penelope Montgomery

|Feb 25, 2026
The important role of comorbidities in the management of obesity.

Sarah R Barenbaum, Beverly G Tchang, Louis J Aronne

|Feb 04, 2026
A treat-to-target approach for obesity management: A post hoc analysis of the SURMOUNT-5 trial.

Carel W le Roux, Luca Busetto, Louis Aronne

|Jan 15, 2026
Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the SURMOUNT-OSA randomized trial.

Atul Malhotra, Ronald Grunstein, Ali Azarbarzin

|Nov 28, 2025
Approach to the Patient: Clinical Outcomes and Interim Strategies Following Discontinuation of Incretin Agonists.

Sarah R Barenbaum, Mohini Aras, Sangeeta Kashyap

Pageof 3

Frequent Collaborators

3 joint publications

Carel W le Roux

3 joint publications

Julia P Dunn

2 joint publications

Sarah R Barenbaum

2 joint publications

Beverly G Tchang